Table 3.
The sequence of crRNAs used in CRISPR-based platforms using for detection and treatment of SARS-CoV-2.
platforms | Target genes | crRNA sequences |
---|---|---|
RT-PCR | N1-CDC FW/Rev primer | GAC CCC AAA ATC AGC GAA AT TCT GGT TAC TGC CAG TTG AAT CTG |
N2-CDC FW/Rev primer | TTA CAA ACA TTG GCC GCA AA GCG CGA CAT TCC GAA GAA |
|
SHERLOCK | S-crRNA_v1 | GAUUUAGACUACCCCAAAAACGAAGGGGACUAAAACGCAGCACC AGCUGUCCAACCUGAAGAAG |
Orf1ab-crRNA_v1 | GAUUUAGACUACCCCAAAAACGAAGGGGACUAAAACCCAACCUCU UCUGUAAUUUUUAAACUAU | |
CREST | N1 | gaaatTAATACGACTCACTATAgggcgaccccaaaatcagcgaaat |
N2 | gaaatTAATACGACTCACTATAgggcttacaaacattggccgcaaa | |
N3 | gaaatTAATACGACTCACTATAgggcgggagccttgaatacaccaaaa | |
DETECTR | N-gRNA 1 | UAAUUUCUACUAAGUGUAGAUCCCCCAGCGCUUCAGCGUUC |
E-gRNA2 | UAAUUUCUACUAAGUGUAGAUGUGGUAUUCUUGCUAGUUAC | |
RNaseP gRNA | UAAUUUCUACUAAGUGUAGAUAAUUACUUGGGUGUGACCCU | |
N-gRNA 1 other species variant |
UAAUUUCUACUAAGUGUAGAUCUCCAAGUGCCUCUGCAUUC | |
N-gRNA 2 | UAAUUUCUACUAAGUGUAGAUGCAAUGUUGUUCCUUGAGGA | |
E-gene gRNA 1 | UAAUUUCUACUAAGUGUAGAUUUGCUUUCGUGGUAUUCUUG | |
CRISPR/Cas12a-NER | orf1a-crRNA1 | TTTGGTGGTGCATCGTGTTGTCTGTAC |
orf1a-crRNA2 | TTTGTGACTTAAAAGGTAAGTATGTAC | |
orf1a-crRNA3 | TTTGTACATACTTACCTTTTAAGTCAC | |
orf1a-crRNA4 | TTTACACTTAAAAACACAGTCTGTACC | |
orf1b-crRNA1 | TTTCACTCAATACTTGAGCACACTCAT | |
orf1b-crRNA2 | TTTTTAACATTTGTCAAGCTGTCACGG | |
orf1b-crRNA3 | TTTTAACATTTGTCAAGCTGTCACGGC | |
orf1b-crRNA4 | TTTGTCAAGCTGTCACGGCCAATGTTA | |
E-crRNA1 | TTTTCTTGCTTTCGTGGTATTCTTGCT | |
E-crRNA2 | TTTCGTGGTATTCTTGCTAGTTACACT | |
E-crRNA3 | TTTACAAGACTCACGTTAACAATATTG | |
E-crRNA4 | TTTACTCTCGTGTTAAAAATCTGAATT | |
N-crRNA1 | TTTCTTGAACTGTTGCGACTACGTGAT | |
N-crRNA2 | TTTGCTGCTGCTTGACAGATTGAACCA | |
N-crRNA3 | TTTACCAGACATTTTGCTCTCAAGCTG | |
PAC-MAN | N1-crRNA N18f | UGAACCAAGACGCAGUAUUAUU |
CONAN | N1-crRNA | ATG TCTGGTAAAGGCCAACAACAACAAGGCCAAAC |
N2-crRNA | AAG GAACTGATTACAAACATTGGCCGCAAATTGCA |